Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Dezember 2016 15:30 ET | Quelle: OpGen, Inc.

OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections

GAITHERSBURG, Md., Dec. 19, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) issued the statement below following the passage of the 21st Century Cures legislation in support for advancing medical...
16. Dezember 2016 09:25 ET | Quelle: OpGen, Inc.

OpGen Provides ATM Program Update

GAITHERSBURG, Md., Dec. 16, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announces that during the fourth quarter of 2016 it has issued approximately 3.6 million shares of its common stock...
14. November 2016 07:00 ET | Quelle: OpGen, Inc.

OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance

GAITHERSBURG, M.d., Nov. 14, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced it has entered into a research collaboration with Merck, known as MSD outside the United States and...
27. Oktober 2016 16:24 ET | Quelle: OpGen, Inc.

Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms

SALT LAKE CITY and GAITHERSBURG, Md., Oct. 27, 2016 (GLOBE NEWSWIRE) -- A first-of-its-kind study of 900,000 hospital admissions from an integrated health system has yielded insights into shifts...
26. Oktober 2016 08:00 ET | Quelle: OpGen, Inc.

OpGen’s Infectious Disease Portfolio Highlighted at IDWeek 2016

GAITHERSBURG, Md., Oct. 26, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that its infectious disease portfolio will be featured in one oral presentation and 5 poster sessions...
24. Oktober 2016 16:01 ET | Quelle: OpGen, Inc.

OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update

GAITHERSBURG, Md., Oct. 24, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the three and nine months ended September 30, 2016. Highlights of...
19. Oktober 2016 17:09 ET | Quelle: OpGen, Inc.

OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call

GAITHERSBURG, Md., Oct. 19, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its third quarter 2016 financial results after close of market on Monday, October...
08. September 2016 07:30 ET | Quelle: OpGen, Inc.

OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress

GAITHERSBURG, Md., Sept. 08, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will participate in the World Anti-Microbial Resistance Congress being held September 8-9 in...
07. September 2016 07:30 ET | Quelle: OpGen, Inc.

OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

GAITHERSBURG, Md., Sept. 07, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) an informatics and genomic analysis company, announces that Evan Jones, the Company’s Chairman and Chief Executive...
09. August 2016 16:02 ET | Quelle: OpGen, Inc.

OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update

GAITHERSBURG, Md., Aug. 09, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the three and six months ended June 30, 2016. Highlights of the...

Vorherige Seite